Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements Limited announced that the National Company Law Tribunal (NCLT), Ahmedabad Bench, has scheduled a hearing for February 19, 2026 on a Scheme of Arrangement petition between Penna Cement Industries Limited (transferor) and Ambuja Cements Limited (transferee). The joint petition was filed December 30, 2025, and the tribunal issued its hearing order January 8, 2026. Interested parties may file opposition notices by February 17, 2026. This merger scheme requires tribunal approval before proceeding.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 17 January 2026?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 17 January 2026

RELIANCE Reliance Industries Limited Financial Results TECHM Tech Mahindra Limited Financial Results WIPRO Wipro Limited Financial Results HDFCBANK HDFC Bank Limited Financial Results HDFCBANK HDFC Bank Limited Financial Results HDFCBANK HDFC Bank Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.